Weekly Snapshot

1.AstraZeneca’s Qternmet XR (dapagliflozin, saxagliptin, metformin hydrochloride) Receives FDA’s Approval for Type-2 Diabetes in the US Published: May 03, 2019 | Tags: AstraZeneca, Qternmet [...]

Novo Nordisk Files MAA for Semaglutide to the EMA for Type 2 Diabetes Published: April 26,2019 | Tags: Novo Nordisk, Files, MAA, Semaglutide, [...]

1.Almac Diagnostic Collaborates with Queen’s University to Bring Personalized Chemotherapy for Esophageal Cancer Published: April 18, 2019 | Tags: Almac Diagnostic, Collaborates, Queen’s [...]

1.Omron Healthcare Receives FDA’s Approval for Complete a Blood Pressure Monitoring Device with ECG Facility Published: April 12, 2019 | Tags: Omron Healthcare, Receives, [...]

Amazon Launches Alexa’s Health Services for Managing Health and Handling Patients Data Published: April 05, 2019 | Tags: Amazon, Launches, Alexa, Health Services, Managing [...]

Takeda Signs a Multi-Target Agreement with StrideBio to Develop Gene Therapies for Neurological Disorders Published: March 29, 2019 | Tags: Takeda, Signs, Multi- Target [...]

Novartis Announces Spin-Off of Alcon Eye Care Business on April 9, 2019 Published: March 22, 2019 | Tags: Novartis, Announces, Spin-Off, Alcon, Eye Care, [...]

1. AbCellera Signs a Research Agreement with Bill & Melinda Gates Foundation to Accelerate Global Health Research Published: March 15, 2019 |Tags: Gates Foundation, Signs, [...]

1.Bayer Submits EU’s Marketing Authorization Application to EMA for Darolutamide Published: 08 Mar,2019 |Tags: Bayer, Submits, EU, Marketing Authorization Application, EMA, Darolutamide2 2. Zeiss’ [...]